Exon B of human surfactant protein A2 mRNA, alone or within its surrounding sequences, interacts with 14-3-3; role of cis-elements and secondary structure

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 304, Issue 11, 2013, Pages

  Noutsios, Georgios T ^a   Silveyra, Patricia ^a   Bhatti, Faizah ^a   Floros, Joanna ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

14 3 3 family of proteins; 5' untranslated regions; Electromobility shift assays; Trans acting factors; Translation

Indexed keywords

ANTIBODY; BINDING PROTEIN; CIS ACTING ELEMENT; CYTOSKELETON PROTEIN; LECTIN; MESSENGER RNA; PROTEIN 14 3 3; PROTEIN 14 3 3 ALPHA; PROTEIN 14 3 3 BETA; SURFACTANT PROTEIN A; SURFACTANT PROTEIN A1; SURFACTANT PROTEIN A2; TRANS ACTING FACTOR; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; EXON; EXON B; GEL MOBILITY SHIFT ASSAY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; RECEPTOR DOWN REGULATION; RNA ELECTROMOBILITY SHIFT ASSAY; RNA SEQUENCE; RNA TRANSLATION; WILD TYPE;

14-3-3 FAMILY OF PROTEINS; 5′ UNTRANSLATED REGIONS; ELECTROMOBILITY SHIFT ASSAYS; TRANS-ACTING FACTORS; TRANSLATION;

14-3-3 PROTEINS; 5' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; EXONS; HUMANS; PROTEIN STRUCTURE, SECONDARY; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RNA, MESSENGER;

EID: 84878650673     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00324.2012     Document Type: Article

References (106)

1. Aitken A. Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants. Plant Mol Biol 50: 993-1010, 2002.
2. Andreassi C, Riccio A. To localize or not to localize: mRNA fate is in 3=UTR ends. Trends Cell Biol 19: 465-474, 2009.
3. Baldin V. 14-3-3 proteins and growth control. Prog Cell Cycle Res 4: 49-60, 2000.
4. Brands JH, Maassen JA, van Hemert FJ, Amons R, Möller W. The primary structure of the alpha subunit of human elongation factor 1. Structural aspects of guanine-nucleotide-binding sites. Eur J Biochem 155: 167-171, 1986.
5. Braselmann S, McCormick F. Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J 14: 4839-4848, 1995.
6. Bridges D, Moorhead GBG. 14-3-3 proteins: a number of functions for a numbered protein. Sci STKE 2004: re10-, 2004.
7. Bruce SR, Atkins CL, Colasurdo GN, Alcorn JL. Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiency. Am J Physiol Lung Cell Mol Physiol 297: L559-L567, 2009.
8. Burlak C, Whitney AR, Mead DJ, Hackstadt T, Deleo FR. Maturation of human neutrophil phagosomes includes incorporation of molecular chaperones and endoplasmic reticulum quality control machinery. Mol Cell Proteomics 5: 620-634, 2006.
9. Casals C, Varela A, Ruano ML, Valiño F, Pérez-Gil J, Torre N, Jorge E, Tendillo F, Castillo-Olivares JL. Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation. Am J Respir Crit Care Med 157: 43-49, 1998.
10. Ceci M, Gaviraghi C, Gorrini C, Sala LA, Offenhäuser N, Marchisio PC, Biffo S. Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly. Nature 426: 579-584, 2003.
11. Chang JH, Cho YH, Sohn SY, Choi JM, Kim A, Kim YC, Jang SK, Cho Y. Crystal structure of the eIF4A-PDCD4 complex. Proc Natl Acad Sci USA 106: 3148-3153, 2009.
12. Cheng ST, Nguyen TQ, Yang YS, Capra JD, Sontheimer RD. Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen. J Immunol 156: 4484-4491, 1996.
13. Clemens MJ, Henshaw EC, Rahamimoff H, London IM. MettRNAfMet binding to 40S ribosomal subunits: a site for the regulation of initiation of protein synthesis by hemin. Proc Natl Acad Sci USA 71: 2946-2950, 1974.
14. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 19: 177-201, 1998.
15. Dabiri GA, Young CL, Rosenbloom J, Southwick FS. Molecular cloning of human macrophage capping protein cDNA. A unique member of the gelsolin/villin family expressed primarily in macrophages. J Biol Chem 267: 16545-16552, 1992.
16. Davezac N, Baldin V, Gabrielli B, Forrest A, Theis-Febvre N, Yashida M, Ducommun B. Regulation of CDC25B phosphatases subcellular localization. Oncogene 19: 2179-2185, 2000.
17. Defrance M, van Helden J. info-gibbs: a motif discovery algorithm that directly optimizes information content during sampling. Bioinformatics 25: 2715-2722, 2009.
18. Dever TE. Gene-specific regulation by general translation factors. Cell 108: 545-556, 2002.
19. DiAngelo S, Lin Z, Wang G, Phillips S, Ramet M, Luo J, Floros J. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 15: 269-281, 1999.
20. Dubois T, Rommel C, Howell S, Steinhussen U, Soneji Y, Morrice N, Moelling K, Aitken A. 14-3-3 is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in vivo regulates Raf/14-3-3 interaction. J Biol Chem 272: 28882-28888, 1997.
21. Esteban R, Vega L, Fujimura T. 20S RNA narnavirus defies the antiviral activity of SKI1/XRN1 in Saccharomyces cerevisiae. J Biol Chem 283: 25812-25820, 2008.
22. Floros J, Thomas N. Genetic variations of surfactant proteins and lung injury. In: Surfactant in Pathogenesis and Treatment of Lung Disease, edited by Nakos G, Papathanasiou A. Trivandrum, India: Research Signpost, 2009, p. 25-48.
23. Floros J, Wang G, Mikerov AN. Genetic complexity of the human innate host defense molecules, surfactant protein A1 (SP-A1) and SPA2-impact on function. Crit Rev Eukaryot Gene Expr 19: 125-137, 2009.
24. Fu H, Subramanian RR, Masters SC. 14-3-3 Proteins: structure, function, regulation. Annu Rev Pharmacol Toxicol 40: 617-647, 2000.
25. Fujita Y, Okamoto T, Noshiro M, McKeehan WL, Crabb JW, Whitney RG, Kato Y, Sato JD, Takada K. A novel heparin-binding protein, HBp15, is identified as mammalian ribosomal protein L22. Biochem Biophys Res Commun 199: 706-713, 1994.
26. García-Verdugo I, Wang G, Floros J, Casals C. Structural analysis and lipid-binding properties of recombinant human surfactant protein a derived from one or both genes. Biochemistry 41: 14041-14053, 2002.
27. Garin J, Diez R, Kieffer S, Dermine JF, Duclos S, Gagnon E, Sadoul R, Rondeau C, Desjardins M. The phagosome proteome: insight into phagosome functions. J Cell Biol 152: 165-180, 2001.
28. Gazda HT, Sheen MR, Vlachos A, Choesmel V, O'Donohue MF, Schneider H, Darras N, Hasman C, Sieff CA, Newburger PE, Ball SE, Niewiadomska E, Matysiak M, Zaucha JM, Glader B, Niemeyer C, Meerpohl JJ, Atsidaftos E, Lipton JM, Gleizes PE, Beggs AH. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 83: 769-780, 2008.
29. Gebauer F, Hentze MW. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 5: 827-835, 2004.
30. Gmitterová K, Heinemann U, Bodemer M, Krasnianski A, Meissner B, Kretzschmar HA, Zerr I. 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiol Aging 30: 1842-1850, 2009.
31. Gruber AR, Lorenz R, Bernhart SH, Neuböck R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res 36: W70-W74, 2008.
32. Gu YM, Jin YH, Choi JK, Baek KH, Yeo CY, Lee KY. Protein kinase A phosphorylates and regulates dimerization of 14-3-3 epsilon. FEBS Lett 580: 305-310, 2006.
33. Guzman J, Wang YM, Kalaycioglu O, Schoenfeld B, Hamm H, Bartsch W, Costabel U. Increased surfactant protein A content in human alveolar macrophages in hypersensitivity pneumonitis. Acta Cytol 36: 668-673, 1992.
34. Hamm H, Lührs J, Guzman y Rotaeche J, Costabel U, Fabel H, Bartsch W. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 106: 1766-1770, 1994.
35. Hemmerich P, von Mikecz A, Neumann F, Sözeri O, Wolff-Vorbeck G, Zoebelein R, Krawinkel U. Structural and functional properties of ribosomal protein L7 from humans and rodents. Nucleic Acids Res 21: 223-231, 1993.
36. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3-11, 1997.
37. Hoffman RW, Gazitt T, Foecking MF, Ortmann RA, Misfeldt M, Jorgenson R, Young SL, Greidinger EL. U1 RNA induces innate immunity signaling. Arthritis Rheum 50: 2891-2896, 2004.
38. Huang W, Wang G, Phelps DS, Al-Mondhiry H, Floros J. Human SP-A genetic variants and bleomycin-induced cytokine production by THP-1 cells: effect of ozone-induced SP-A oxidation. Am J Physiol Lung Cell Mol Physiol 286: L546-L553, 2004.
39. Inoue A, Xin H, Suzuki T, Kanehira M, Kuroki Y, Fukuhara T, Kikuchi T, Maemondo M, Nukiwa T, Saijo Y. Suppression of surfactant protein A by an epidermal growth factor receptor tyrosine kinase inhibitor exacerbates lung inflammation. Cancer Sci 99: 1679-1684, 2008.
40. Jang SW, Liu X, Fu H, Rees H, Yepes M, Levey A, Ye K. Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons. J Biol Chem 284: 24512-24525, 2009.
41. Jin Y, Dai MS, Lu SZ, Xu Y, Luo Z, Zhao Y, Lu H. 14-3-3 binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J 25: 1207-1218, 2006.
42. Jønson L, Vikesaa J, Krogh A, Nielsen LK, Hansen T, Borup R, Johnsen AH, Christiansen J, Nielsen FC. Molecular composition of IMP1 ribonucleoprotein granules. Mol Cell Proteomics 6: 798-811, 2007.
43. Karinch AM, Deiter G, Ballard PL, Floros J. Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture. Biochim Biophys Acta 1398: 192-202, 1998.
44. Karinch AM, Floros J. 5= Splicing and allelic variants of the human pulmonary surfactant protein A genes. Am J Respir Cell Mol Biol 12: 77-88, 1995.
45. Karinch AM, Floros J. Translation in vivo of 5= untranslated-region splice variants of human surfactant protein-A. Biochem J 307: 327-330, 1995.
46. Kumar AR, Snyder JM. Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin. Am J Physiol Lung Cell Mol Physiol 274: L177-L185, 1998.
47. Le Quesne JP, Spriggs KA, Bushell M, Willis AE. Dysregulation of protein synthesis and disease. J Pathol 220: 140-151, 2010.
48. Liu Y, Ross JF, Bodine PV, Billiard J. Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-3β phosphorylation and promotes osteoblast differentiation and bone formation. Mol Endocrinol 21: 3050-3061, 2007.
49. Liu Y, Wimmer E, Paul AV. Cis-acting RNA elements in human and animal plus-strand RNA viruses. Biochim Biophys Acta 1789: 495-517, 2009.
50. Loh PG, Yang HS, Walsh MA, Wang Q, Wang X, Cheng Z, Liu D, Song H. Structural basis for translational inhibition by the tumour suppressor Pdcd4. EMBO J 28: 274-285, 2009.
51. Margolis SS, Walsh S, Weiser DC, Yoshida M, Shenolikar S, Kornbluth S. PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J 22: 5734-5745, 2003.
52. Martin TR, Frevert CW. Innate immunity in the lungs. Proc Am Thorac Soc 2: 403-411, 2005.
53. Mathews MB. Lost in translation. Trends Biochem Sci 27: 267-269, 2002.
54. McCormick SM, Boggaram V, Mendelson CR. Characterization of mRNA transcripts and organization of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 266: L354-L366, 1994.
55. Meyer KC, Sharma A, Brown R, Weatherly M, Moya FR, Lewandoski J, Zimmerman JJ. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis. Chest 118: 164-174, 2000.
56. Mikerov A, Wang G, Umstead T, Zacharatos M, Thomas N, Phelps D, Floros J. Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun 75: 1403-1412, 2007.
57. Mikerov AN, Umstead TM, Gan X, Huang W, Guo X, Wang G, Phelps DS, Floros J. Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants. Am J Physiol Lung Cell Mol Physiol 294: L121-L130, 2008.
58. Mikerov AN, Umstead TM, Huang W, Liu W, Phelps D, Floros J. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 288: L150-L158, 2005.
59. Murakami S, Iwaki D, Mitsuzawa H, Sano H, Takahashi H, Voelker DR, Akino T, Kuroki Y. Surfactant protein A inhibits peptidoglycaninduced tumor necrosis factor-β secretion in U937 cells and alveolar macrophages by direct interaction with Toll-like receptor 2. J Biol Chem 277: 6830-6837, 2002.
60. Muslin AJ, Xing H. 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal 12: 703-709, 2000.
61. Obsil T, Ghirlando R, Klein DC, Ganguly S, Dyda F. Crystal structure of the 14-3-3zeta:serotonin N-acetyltransferase complex. A role for scaffolding in enzyme regulation. Cell 105: 257-267, 2001.
62. Pesole G, Mignone F, Gissi C, Grillo G, Licciulli F, Liuni S. Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276: 73-81, 2001.
63. Phelps DS. Surfactant regulation of host defense function in the lung: a question of balance. Pediatr Pathol Mol Med 20: 269-292, 2001.
64. Phelps DS, Umstead TM, Quintero OA, Yengo CM, Floros J. In vivo rescue of alveolar macrophages from SP-A knockout mice with exogenous SP-A nearly restores a wild type intracellular proteome; actin involvement. Proteome Sci 9: 67, 2011.
65. Postle AD, Mander A, Reid KB, Wang JY, Wright SM, Moustaki M, Warner JO. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol 20: 90-98, 1999.
66. Powell DW, Rane MJ, Chen Q, Singh S, McLeish KR. Identification of 14-3-3ξ as a protein kinase B/Akt substrate. J Biol Chem 277: 21639-21642, 2002.
67. Powell DW, Rane MJ, Joughin BA, Kalmukova R, Hong JH, Tidor B, Dean WL, Pierce WM, Klein JB, Yaffe MB, McLeish KR. Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding. Mol Cell Biol 23: 5376-5387, 2003.
68. Pozuelo Rubio M, Geraghty KM, Wong BH, Wood NT, Campbell DG, Morrice N, Mackintosh C. 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J 379: 395-408, 2004.
69. Qi Y, Ding B. Inhibition of cell growth and shoot development by a specific nucleotide sequence in a noncoding viroid RNA. Plant Cell 15: 1360-1374, 2003.
70. Richter NJ, Rogers GW, Hensold JO, Merrick WC. Further biochemical and kinetic characterization of human eukaryotic initiation factor 4H. J Biol Chem 274: 35415-35424, 1999.
71. Robledo S, Idol RA, Crimmins DL, Ladenson JH, Mason PJ, Bessler M. The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA 14: 1918-1929, 2008.
72. Rogers GW, Richter NJ, Lima WF, Merrick WC. Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F. J Biol Chem 276: 30914-30922, 2001.
73. Sato S, Fujita N, Tsuruo T. Regulation of kinase activity of 3-phosphoinositide-dependent protein kinase-1 by binding to 14-3-3. J Biol Chem 277: 39360-39367, 2002.
74. Scavo LM, Ertsey R, Gao BQ. Human surfactant proteins A1 and A2 are differentially regulated during development and by soluble factors. Am J Physiol Lung Cell Mol Physiol 275: L653-L669, 1998.
75. Schuster TB, Costina V, Findeisen P, Neumaier M, Ahmad-Nejad P. Identification and functional characterization of 14-3-3 in TLR2 signaling. J Proteome Res 10: 4661-4670, 2011.
76. Schütz P, Karlberg T, van den Berg S, Collins R, Lehtiö L, Högbom M, Holmberg-Schiavone L, Tempel W, Park HW, Hammarström M, Moche M, Thorsell AG, Schüler H. Comparative structural analysis of human DEAD-box RNA helicases. PLoS One 5, 2010.
77. Shannon JM, Pan T, Edeen KE, Nielsen LD. Influence of the cytoskeleton on surfactant protein gene expression in cultured rat alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 274: L87-L96, 1998.
78. Silveyra P, Floros J. Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury. Front Biosci 17: 407-429, 2012.
79. Silveyra P, Raval M, Simmons B, Diangelo S, Wang G, Floros J. The untranslated exon B of human surfactant protein A2 mRNAs is an enhancer for transcription and translation. Am J Physiol Lung Cell Mol Physiol 301: L795-L803, 2011.
80. Silveyra P, Wang G, Floros J. Human SP-A1 (SFTPA1) variantspecific 3= UTRs and poly(A) tail differentially affect the in vitro translation of a reporter gene. Am J Physiol Lung Cell Mol Physiol 299: L523-L534, 2010.
81. Skoulakis EM, Davis RL. 14-3-3 proteins in neuronal development and function. Mol Neurobiol 16: 269-284, 1998.
82. Sonenberg N. Cap-binding proteins of eukaryotic messenger RNA: functions in initiation and control of translation. Prog Nucleic Acid Res Mol Biol 35: 173-207, 1988.
83. Sonenberg N, Dever TE. Eukaryotic translation initiation factors and regulators. Curr Opin Struct Biol 13: 56-63, 2003.
84. Stothard P. The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences. Biotechniques 28: 1102, 1104, 2000.
85. Tagaram HR, Wang G, Umstead TM, Mikerov AN, Thomas NJ, Graff GR, Hess JC, Thomassen MJ, Kavuru MS, Phelps DS, Floros J. Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol 292: L1052-L1063, 2007.
86. Todd A, Cossons N, Aitken A, Price GB, Zannis-Hadjopoulos M. Human cruciform binding protein belongs to the 14-3-3 family. Biochemistry 37: 14317-14325, 1998.
87. Troyanovsky SM, Leube RE, Franke WW. Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol 59: 127-137, 1992.
88. Ulvila J, Vanha-aho LM, Kleino A, Vähä-Mäkilä M, Vuoksio M, Eskelinen S, Hultmark D, Kocks C, Hallman M, Parikka M, Rämet M. Cofilin regulator 14-3-3ξ is an evolutionarily conserved protein required for phagocytosis and microbial resistance. J Leukoc Biol 89: 649-659, 2011.
89. van Hemert MJ, Steensma HY, van Heusden GP. 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23: 936-946, 2001.
90. Vladimirov SN, Ivanov AV, Karpova GG, Musolyamov AK, Egorov TA, Thiede B, Wittmann-Liebold B, Otto A. Characterization of the human small-ribosomal-subunit proteins by N-terminal and internal sequencing, and mass spectrometry. Eur J Biochem 239: 144-149, 1996.
91. Wang G, Bates-Kenney SR, Tao JQ, Phelps DS, Floros J. Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry 43: 4227-4239, 2004.
92. Wang G, Guo X, Diangelo S, Thomas NJ, Floros J. Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1 and SP-A2: formation of tubular myelin in vivo requires both gene products. J Biol Chem 285: 11998-12010, 2010.
93. Wang G, Guo X, Floros J. Differences in the translation efficiency and mRNA stability mediated by 5=-UTR splice variants of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 289: L497-L508, 2005.
94. Wang G, Guo X, Floros J. Human SP-A 3=-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone. Am J Physiol Lung Cell Mol Physiol 284: L738-L748, 2003.
95. Wang G, Guo X, Silveyra P, Kimball SR, Floros J. Cap-independent translation of human SP-A 5=-UTR variants: a double-loop structure and cis-element contribution. Am J Physiol Lung Cell Mol Physiol 296: L635-L647, 2009.
96. Wang G, Myers C, Mikerov A, Floros J. Role of Cys85 of human SP-A variants on their biochemical properties and biological function. FASEB J 21: A552, 2007.
97. Wang G, Phelps DS, Umstead TM, Floros J. Human SP-A protein variants derived from one or both genes stimulate TNF-α production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol 278: L946-L954, 2000.
98. Wang G, Taneva S, Keough KM, Floros J. Differential effects of human SP-A1 and SP-A2 variants on phospholipid monolayers containing surfactant protein B. Biochim Biophys Acta 1768: 2060-2069, 2007.
99. Wang JY, Reid KB. The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation. Immunobiology 212: 417-425, 2007.
100. Wang Y, Voelker DR, Lugogo NL, Wang G, Floros J, Ingram JL, Chu HW, Church TD, Kandasamy P, Fertel D, Wright JR, Kraft M. Surfactant protein A is defective in abrogating inflammation in asthma. Am J Physiol Lung Cell Mol Physiol 301: L598-L606, 2011.
101. Wassenegger M, Spieker RL, Thalmeir S, Gast FU, Riedel L, Sänger HL. A single nucleotide substitution converts potato spindle tuber viroid (PSTVd) from a noninfectious to an infectious RNA for Nicotiana tabacum. Virology 226: 191-197, 1996.
102. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW, Swanstrom R, Burch CL, Weeks KM. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460: 711-716, 2009.
103. Weinlich S, Hüttelmaier S, Schierhorn A, Behrens SE, Ostareck-Lederer A, Ostareck DH. IGF2BP1 enhances HCV IRES-mediated translation initiation via the 3=UTR. RNA 15: 1528-1542, 2009.
104. Wilker EW, van Vugt MA, Artim SA, Huang PH, Petersen CP, Reinhardt HC, Feng Y, Sharp PA, Sonenberg N, White FM, Yaffe MB. 14-3-3σ controls mitotic translation to facilitate cytokinesis. Nature 446: 329-332, 2007.
105. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 77: 931-962, 1997.
106. Yu Y, Ji H, Doudna JA, Leary JA. Mass spectrometric analysis of the human 40S ribosomal subunit: native and HCV IRES-bound complexes. Protein Sci 14: 1438-1446, 2005